<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33618928</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-1497</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neurobiology of aging</Title><ISOAbbreviation>Neurobiol Aging</ISOAbbreviation></Journal><ArticleTitle>Genetic epidemiology of familial ALS in Brazil.</ArticleTitle><Pagination><StartPage>227.e1</StartPage><EndPage>227.e4</EndPage><MedlinePgn>227.e1-227.e4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurobiolaging.2021.01.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0197-4580(21)00014-2</ELocationID><Abstract><AbstractText>Many genes associated with familial forms of the amyotrophic lateral sclerosis (fALS) have been identified in European and North American cohorts. However, little is known about the genetic bases of fALS in Latin America and Brazil, in particular. To address this question, we recruited 107 patients with fALS from 93 unrelated families from Southeastern, Southern, and Northeastern regions of the country. A 3-step diagnostic approach was used: 1) Triplet repeat primed polymerase chain reaction to search for C9orf72 expansions, then 2) fragment digestion to search for the c.166&#xa0;C&gt;T VAPB variant, and finally, 3) whole exome sequencing for those who tested negative. We identified the genetic cause for fALS in 70% of the families. VAPB and C9orf72 were the most frequent genes (30% and 22%, respectively), followed by SOD1, TARDBP, ANXA11, and FUS. Five novel variants in known ALS genes were found, including the SOD1 Val120Leu and ANXA11 Asp40Tyr, which were seen in 2 unrelated families each. In conclusion, VAPB and then C9orf72 are the genes most commonly related to fALS in Brazil.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nunes Gon&#xe7;alves</LastName><ForeName>Jo&#xe3;o Pedro</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Medical Genetics, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, BRAZIL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leoni</LastName><ForeName>Tauana Bernardes</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Medical Genetics, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, BRAZIL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Melina Pazian</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Medical Genetics, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, BRAZIL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peluzzo</LastName><ForeName>Thiago Mazzo</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Medical Genetics, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, BRAZIL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dourado</LastName><ForeName>Mario Em&#xed;lio T</ForeName><Initials>MET</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Integrative Medicine, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saute</LastName><ForeName>Jonas Alex M</ForeName><Initials>JAM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paranhos Miranda Covaleski</LastName><ForeName>Anna Paula</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Federal University of Pernambuco, Recife, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulle de Oliveira</LastName><ForeName>Acary Souza</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neuromuscular Disorders Unit, Federal University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claudino</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Federal University of Santa Catarina, Florian&#xf3;polis, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Wilson</ForeName><Initials>W</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Neurosciences and Behavior Sciences, Ribeir&#xe3;o Preto School of Medicine, University of S&#xe3;o Paulo (HCFMRP-USP), Ribeir&#xe3;o Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nucci</LastName><ForeName>Anamarli</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Medical Genetics, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, BRAZIL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fran&#xe7;a</LastName><ForeName>Marcondes C</ForeName><Initials>MC</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Departments of Neurology and Medical Genetics, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, BRAZIL. Electronic address: mcfjr@unicamp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurobiol Aging</MedlineTA><NlmUniqueID>8100437</NlmUniqueID><ISSNLinking>0197-4580</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496748">VAPB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073359" MajorTopicYN="N">Exome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">VAPB</Keyword><Keyword MajorTopicYN="N">Whole exome sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33618928</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.01.007</ArticleId><ArticleId IdType="pii">S0197-4580(21)00014-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>